Labiotech provides listing of 2026 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions.

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.

Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...

Based in Switzerland, Alentis Therapeutics is a clinical-stage biotech company developing first-in-class therapies that target Claudin-1 (CLDN1), a tight-junction protein abnormally expressed in ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

It’s summertime and what’s better than to curl up in bed, or under a shady tree, or by the pool, and read a good book? We have curated a list of some of the best biotech books that are bound to get ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.

The biotech job market was set back last year and may only see a full recovery in 2025-2026, meaning the competition in the industry is fierce for candidates who might have to compete on fewer job ...